Characterization of the poliovirus 147S particle:: New insights into poliovirus uncoating

被引:6
|
作者
Pelletier, I
Ouzilou, L
Arita, M
Nomoto, A
Colbère-Garapin, F
机构
[1] Inst Pasteur, Unite Neurovirol & Regenerat Syst Nerveux, F-75724 Paris, France
[2] Nat Inst Infect Dis, Dept Virol 2, Musashimurayama, Tokyo 2080011, Japan
[3] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan
关键词
D O I
10.1006/viro.2002.1736
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A Sabin 1 strain poliovirus (PV) mutant, S1(2Y-1l), carrying a Tyr at amino acid position VP2(142) and an Ile at position VP1(160), can establish persistent infections in HEp-2c cells. This mutant forms atypical 147S particles upon interaction at 0degreesC with either cells expressing PV receptor (PVR) CD155, or PVR-IgG2a, a chimeric molecule consisting of an extracellular moiety of PVR and the hinge and Fc portion of a mouse IgG2a. Upon interaction with PVR at 37degreesC, S1(2Y-1l), similar to the parental strain, forms both 135S A particles and 80S empty capsids. At 0degreesC, surprisingly, at a concentration equal to or greater than 5 nM, PVR-IgG2a induced both the extrusion of VP4 from the capsid of S1 (2Y-1l) and the formation of 80S particles. The same transitions were observed at 0degreesC with the parental strain Sabin 1 at 40 nM PVR-IgG2a. Thus, the formation of 80S particles and VP4 extrusion, considered as one of the steps of PV uncoating, can be temperature-independent at high PVR concentration. This implies that structural changes of the PV capsid occurred following adsorption at low temperature. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:55 / 65
页数:11
相关论文
共 24 条
  • [1] INHIBITION OF UNCOATING OF POLIOVIRUS BY ARILDONE, A NEW ANTI-VIRAL DRUG
    MCSHARRY, JJ
    CALIGUIRI, LA
    EGGERS, HJ
    [J]. VIROLOGY, 1979, 97 (02) : 307 - 315
  • [2] STUDIES ON INVITRO UNCOATING OF POLIOVIRUS .2. CHARACTERISTICS OF MEMBRANE-MODIFIED PARTICLE
    DESENA, J
    MANDEL, B
    [J]. VIROLOGY, 1977, 78 (02) : 554 - 566
  • [3] PREVENTION OF RHINOVIRUS AND POLIOVIRUS UNCOATING BY WIN-51711, A NEW ANTIVIRAL DRUG
    FOX, MP
    OTTO, MJ
    MCKINLAY, MA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (01) : 110 - 116
  • [4] Poliovirus: New insights from an old paradigm
    Wien, MW
    Chow, M
    Hogle, JM
    [J]. STRUCTURE, 1996, 4 (07) : 763 - 767
  • [5] The poliovirus 135S particle is infectious
    Curry, S
    Chow, M
    Hogle, JM
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (10) : 7125 - 7131
  • [6] STUDIES ON INVITRO UNCOATING OF POLIOVIRUS .1. CHARACTERIZATION OF MODIFYING FACTOR AND MODIFYING REACTION
    DESENA, J
    MANDEL, B
    [J]. VIROLOGY, 1976, 70 (02) : 470 - 483
  • [7] CHARACTERIZATION OF SOME POLIOVIRUS TEMPERATURE-SENSITIVE MUTANTS AND POLIOVIRUS-RELATED PARTICLE FORMATION UNDER NONPERMISSIVE CONDITIONS
    MIKHEJEV.A
    YAKOBSON, E
    SOLOVIEV, GY
    [J]. JOURNAL OF VIROLOGY, 1970, 6 (02) : 188 - &
  • [8] REVERTANTS OF POLIOVIRUS ESCAPE MUTANTS - NEW INSIGHTS INTO ANTIGENIC STRUCTURES
    KETTERLINUS, R
    WIEGERS, K
    DERNICK, R
    [J]. VIROLOGY, 1993, 192 (02) : 525 - 533
  • [9] CHARACTERIZATION AND ROLE IN MORPHOGENESIS OF A NEW SUBVIRAL PARTICLE (55S) ISOLATED FROM POLIOVIRUS-INFECTED CELLS
    CORRIAS, MV
    FLORE, O
    BROI, E
    MARONGIU, ME
    PANI, A
    TORELLI, S
    LACOLLA, P
    [J]. JOURNAL OF VIROLOGY, 1987, 61 (02) : 561 - 569
  • [10] CHARACTERIZATION OF A NEW ISOLATE OF POLIOVIRUS DEFECTIVE INTERFERING PARTICLES
    LUNDQUIST, RE
    SULLIVAN, M
    MAIZEL, JV
    [J]. CELL, 1979, 18 (03) : 759 - 769